Childhood nephrolithiasis and nephrocalcinosis caused by metabolic diseases and renal tubulopathy

References

1. 1.↵
   1. Weigert A,
   2. Hoppe B.

   Nephrolithiasis and nephrocalcinosis in childhood-risk factor-related current and future treatment options. Front Pediatr 2018; 6: 98.

   OpenUrl
2. 2.↵
   1. Magni G,
   2. Unwin RJ,
   3. Moochhala SH.

   Renal tubular acidosis (RTA) and kidney stones: diagnosis and management. Arch Esp Urol 2021; 74: 123–128.

   OpenUrl
3. 3.↵
   1. Faller N,
   2. Dhayat NA,
   3. Fuster DG.

   Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules. Urolithiasis 2019; 47: 43–56.

   OpenUrl
4. 4.↵
   1. Plain A,
   2. Alexander RT.

   Claudins and nephrolithiasis. Curr Opin Nephrol Hypertens 2018; 27: 268–276.

   OpenUrlPubMed
5. 5.↵
   1. Ratkalkar VN,
   2. Kleinman JG.

   Mechanisms of stone formation. Clin Rev Bone Miner Metab 2011; 9: 187–197.

   OpenUrlPubMed
6. 6.↵
   1. Edvardsson VO,
   2. Goldfarb DS,
   3. Lieske JC,
   4. Beara-Lasic L,
   5. Anglani F,
   6. Milliner DS, et al.

   Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 2013; 28: 1923–1942.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Hernandez JD,
   2. Ellison JS,
   3. Lendvay TS.

   Current trends, evaluation, and management of pediatric nephrolithiasis. JAMA Pediatr 2015; 169: 964–970.

   OpenUrl
8. 8.↵
   1. Boyce AM,
   2. Shawker TH,
   3. Hill SC,
   4. Choyke PL,
   5. Hill MC,
   6. James R, et al.

   Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism. J Clin Endocrinol Metab 2013; 98: 989–994.

   OpenUrlCrossRefPubMed
9. 9.
   1. Matos V,
   2. van Melle G,
   3. Boulat O,
   4. Markert M,
   5. Bachmann C,
   6. Guignard JP.

   Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr 1997; 131: 252–257.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Salvador CL,
    2. Tøndel C,
    3. Rowe AD,
    4. Bjerre A,
    5. Brun A,
    6. Brackman D, et al.

    Estimating glomerular filtration rate in children: evaluation of creatinine- and cystatin C-based equations. Pediatr Nephrol 2019; 34: 301–311.

    OpenUrl
11. 11.↵
    1. Hoppe B,
    2. Martin-Higueras C.

    Inherited conditions resulting in nephrolithiasis. Curr Opin Pediatr 2020; 32: 273–283.

    OpenUrl
12. 12.↵
    1. Braun DA,
    2. Lawson JA,
    3. Gee HY,
    4. Halbritter J,
    5. Shril S,
    6. Tan W, et al.

    Prevalence of monogenic causes in pediatric patients with nephrolithiasis or nephrocalcinosis. Clin J Am Soc Nephrol 2016; 11: 664–672.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Marzuillo P,
    2. Guarino S,
    3. Apicella A,
    4. La Manna A,
    5. Polito C.

    Why we need a higher suspicion index of urolithiasis in children. J Pediatr Urol 2017; 13: 164–171.

    OpenUrl
14. 14.↵
    1. Tasian GE,
    2. Copelovitch L.

    Evaluation and medical management of kidney stones in children. J Urol 2014; 192: 1329–1336.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Copelovitch L.

    Urolithiasis in children: medical approach. Pediatr Clin North Am 2012; 59: 881–896.

    OpenUrlPubMed
16. 16.↵
    1. Kokorowski PJ,
    2. Hubert K,
    3. Nelson CP.

    Evaluation of pediatric nephrolithiasis. Indian J Urol 2010; 26: 531–535.

    OpenUrlPubMed
17. 17.↵
    1. Daga A,
    2. Majmundar AJ,
    3. Braun DA,
    4. Gee HY,
    5. Lawson JA,
    6. Shril S, et al.

    Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int 2018; 93: 204–213.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Halbritter J,
    2. Baum M,
    3. Hynes AM,
    4. Rice SJ,
    5. Thwaites DT,
    6. Gucev ZS, et al.

    Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol 2015; 26: 543–551.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Alpay H,
    2. Ozen A,
    3. Gokce I,
    4. Biyikli N.

    Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 2009; 24: 2203–2209.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Cameron MA,
    2. Sakhaee K,
    3. Moe OW.

    Nephrolithiasis in children. Pediatr Nephrol 2005; 20: 1587–1592.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Nicoletta JA,
    2. Lande MB.

    Medical evaluation and treatment of urolithiasis. Pediatr Clin North Am 2006; 53: 479–491.

    OpenUrlPubMed
22. 22.↵
    1. Alghamdi M,
    2. Alhasan KA,
    3. Taha Elawad A,
    4. Salim S,
    5. Abdelhakim M,
    6. Nashabat M, et al.

    Diversity of phenotype and genetic etiology of 23 cystinuria Saudi patients: a retrospective study. Front Pediatr 2020; 8: 569389.

    OpenUrl
23. 23.↵
    1. Hess B,
    2. Michel R,
    3. Takkinen R,
    4. Ackermann D,
    5. Jaeger P.

    Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list. Nephrol Dial Transplant 1994; 9: 642–649.

    OpenUrlPubMedWeb of Science
24. 24.↵
    1. Kari JA,
    2. Farouq M,
    3. Alshaya HO.

    Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol 2003; 18: 506–510.

    OpenUrlPubMedWeb of Science
25. 25.↵
    1. Konrad M,
    2. Hou J,
    3. Weber S,
    4. Dötsch J,
    5. Kari JA,
    6. Seeman T, et al.

    CLDN16 genotype predicts renal decline in familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2008; 19: 171–181.

    OpenUrlFREE Full Text
26. 26.↵
    National Center for Biotechnology Information. Hereditary distal renal tubular acidosis. [Updated 2019; 2021 Dec]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547595/
27. 27.↵
    1. Lopez-Garcia SC,
    2. Emma F,
    3. Walsh SB,
    4. Fila M,
    5. Hooman N,
    6. Zaniew M, et al.

    Treatment and long-term outcome in primary distal renal tubular acidosis. Nephrol Dial Transplant 2019; 34: 981–991.

    OpenUrl